PRIORITY MEDICINES (PRIME) SCHEME: EVALUATION OF MEDICINES PREVIOUSLY CATEGORIZED IN THE SCHEME AND THEIR CURRENT STATUS
Present review article includes analysis of recently launched PRIME scheme of EMA with the criteria for enrolment. The information related to the benefits that patients and medicine developers can get if they register their drug under this scheme are also discussed. Article also discusses enrolled medicines from the perspective of their therapeutic area/indication, current state of development and authorization status.
Keywords: Advanced therapy medicinal product, Biological preparations, PRIME, Unmet medical need.
[Full Text Article]